ACLX - Arcellx, Inc.

114.3
0.250   0.219%

Share volume: 1,294,952
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%
$114.05
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-09-2024 08-08-2024 11-07-2024 02-27-2025 05-08-2025 11-05-2025 02-26-2026
Total revenue 39.256 M 27.384 M 26.030 M 15.266 M 8.129 M 4.949 M 1.654 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 39.256 M 27.384 M 26.030 M 15.266 M 8.129 M 4.949 M 1.654 M
    -30.24% -4.94% -41.35% -46.75% -39.12% -66.58%  
Operating expenses 55.066 M 62.377 M 59.646 M 68.418 M 77.027 M 66.725 M 65.337 M
Selling general and admin 22.748 M 21.424 M 20.473 M 23.769 M 26.226 M 31.637 M 31.242 M
Research and development 32.318 M 40.953 M 39.173 M 44.649 M 50.801 M 35.088 M 34.095 M
Total expenses 55.066 M 62.377 M 59.646 M 68.418 M 77.027 M 66.725 M 65.337 M
    13.28% -4.38% 14.71% 12.58% -13.37% -2.08%  
Operating income -15.810 M -34.993 M -33.616 M -53.152 M -68.898 M -61.776 M -63.683 M
Ebit -7.198 M -26.861 M -25.644 M -78.898 M -68.910 M -61.776 M -63.683 M
Pretax income -7.198 M -26.861 M -25.644 M -45.576 M -62.270 M -55.781 M -58.072 M
    273.17% -4.53% 77.73% 36.63% -10.42% 4.11%  
Income tax 0.000 341.000 K 223.000 K 1.505 M 0.000 0.000 40.000 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -7.198 M -27.202 M -25.867 M -47.081 M -62.270 M -55.781 M -58.112 M
    -277.91% 4.91% -82.01% -32.26% 10.42% -4.18%